Type |
Details |
Score |
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
36
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu J |
Year: |
2008 |
Journal: |
Biochem Biophys Res Commun |
Title: |
The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. |
Volume: |
367 |
Issue: |
4 |
Pages: |
805-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Z |
Year: |
2017 |
Journal: |
Cell Rep |
Title: |
HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients. |
Volume: |
19 |
Issue: |
12 |
Pages: |
2515-2528 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2013 |
Journal: |
Neoplasia |
Title: |
The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1. |
Volume: |
15 |
Issue: |
1 |
Pages: |
39-48 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
E3 ubiquitin-protein ligase HECTD3 is an E3 ubiquitin ligase that regulates ubiquitination and degradation of Tara [], MASTL and LKB1 []. HECTD3 interacts with HSP90 and is involved in the HSP90-dependent degradation of CRAF protein []. It has been shown to interact and stabilize MALT1 (mucosa-associated lymphoid tissue 1), and may hence promote cell survival []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Glover DM |
Year: |
2012 |
Journal: |
Open Biol |
Title: |
The overlooked greatwall: a new perspective on mitotic control. |
Volume: |
2 |
Issue: |
3 |
Pages: |
120023 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lorca T |
Year: |
2013 |
Journal: |
Oncogene |
Title: |
The Greatwall kinase: a new pathway in the control of the cell cycle. |
Volume: |
32 |
Issue: |
5 |
Pages: |
537-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng A |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Greatwall and Polo-like kinase 1 coordinate to promote checkpoint recovery. |
Volume: |
286 |
Issue: |
33 |
Pages: |
28996-9004 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The MASTL kinases carry only a catalytic domain, which contains a long insertion relative to MAST kinases. MASTL, also called greatwall kinase (Gwl), is involved in the regulation of mitotic entry, which is controlled by the coordinated activities of protein kinases and opposing protein phosphatases (PPs) []. The cyclin B/CDK1 complex induces entry into M-phase while PP2A-B55 shows anti-mitotic activity. MASTL/Gwl is activated downstream of cyclin B/CDK1 and indirectly inhibits PP2A-B55 by phosphorylating the small protein alpha-endosulfine (Ensa) or the cAMP-regulated phosphoprotein 19 (Arpp19), resulting in M-phase progression []. Gwl kinase may also play roles in mRNA stabilization and DNA checkpoint recovery [, ]. The human MASTL gene has also been named FLJ14813; a missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Manchado E |
Year: |
2010 |
Journal: |
Cancer Cell |
Title: |
Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase. |
Volume: |
18 |
Issue: |
6 |
Pages: |
641-54 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
861
 |
Fragment?: |
false |
|
•
•
•
•
•
|